Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

This study has been completed.
Sponsor:
Collaborators:
Bristol-Myers Squibb
Department of Psychiatry, Jamaica Hospital Medical Center
Research Division
Information provided by:
Jamaica Hospital Medical Center
ClinicalTrials.gov Identifier:
NCT00374348
First received: September 7, 2006
Last updated: September 15, 2011
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)